- <25<$5M
1
- <25$8.5M
2
- 68$16.9M
3
- <25$29.6M
4
- 77$25.3M
5
- 34$8.6M
6
Research
Business Services · Arizona, United States · 44 Employees
RCT is a Tucson, Ariz.-based technology investment and management company that provides early-stage funding and development for promising biomedical companies and technologies. RCT focuses on technology investments with origins from universities and research institutions worldwide. RCT's technology portfolio includes platforms that support the discovery, development and manufacturing of therapeutics. Current platform technologies include Pichia and E.coli protein expression systems and novel protein binding scaffolds.Read More
View Company Info for Free
Who is Research
Headquarters
Phone Number
Website
Revenue
Industry
Top Competitors of Research
Research Org Chart
Research Company Metrics
Oct 23, 2014
Translational Drug Development (TD2)
See More Acquisitions & Subsidiaries
Research Tech Stack
Top Companies in United States
Top 10 companies in United States by revenue
Top 10 companies in United States by number of employees
Top 10 companies in United States by total funding amount
Research News & Media
C-Path Launches Unique Translational Therapeutics Accelerator with Support from Cottrell Foundation
The global accelerator will transform academic discoveries to drug development opportunities TUCSON, Ariz., June 9, 2022 /PRNewswire/ -- Critical Path Institute (C-Path) today announced it has been awarded a grant from the Frederick Gardner Cottrell Foundation, a non-profit organization...RCT Acquires Translational Drug Development, LLC
TUCSON, Ariz. & SCOTTSDALE, Ariz.--(BUSINESS WIRE)--Research Corporation Technologies, Inc. (RCT) announced today that it has acquired and invested growth capital into Translational Drug Development (TD2), the leading fully integrated precision oncology medicine development organization. TD2 provides end-to-end solutions, including translational preclinical services; regulatory strategic guidance, planning and document submission services; and clinical trial design and execution for innovatiHalo Labs Raises $5.6M in Series B Financing Round
SAN FRANCISCO, Dec. 20, 2018 /PRNewswire/ -- Halo Labs, a life science instrumentation company developing tools for biologics researchers, today announced it has closed a $5.6M Series B financing round led by Research Corporation Technologies (RCT). The funding will be used to support the ...
Frequently Asked Questions regarding Research
RCT is a Tucson, Ariz.-based technology investment and management company that provides early-stage funding and development for promising biomedical companies and technologies. RCT focuses on technology investments with origins from universities and research institutions worldwide. RCT's technology portfolio includes platforms that support the disc... Read More